MRD / Regn No. : 4233 Date : 03/07/2026
Patient Name : Naina Baid Age & Gender : 50 Yrs. / Female
Contact No. : 9007054935 UHID :
Ht / Wt / BMI : 162 / 97 / 36.96 BP S / BP D : 116 / 82
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (13/Sep/2000) | DYSLIPIDEMIA (13/Sep/2022) | METFORMIN INTOLERANCE (24/Aug/2023) |
Salient Investigations : CREATININE: 0.55 | EGFR EGLOMERULAR FILTRATION RATE: 125.26 mL/min/1.73m2 | HB HEMOGLOBIN: 13.4 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 8 % | LDL LOW DENSITY LIPOPROTEIN: 99 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 ATORVASTATIN 20 MG
X-TOR 		PO 0-0-1 BEFORE FOOD
 TILL NEXT VISIT
2 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES 		SQ 40-0-35 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
3 TABLET DAPAGLIFLOZIN 10 MG
FORXIGA
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
4 ANTIHYPERGLYCEMIC SEMAGLUTIDE 5.0 MG
OZEMPIC 0.5 MG 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 03/Jan/2027
Tests Suggested For Next Visit : SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR: SPOT SAMPLE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: